• Wednesday, Sep 28, 2022
  • Last Update : 10:24 am

Bangladesh clears Johnson & Johnson’s single-dose Covid-19 vaccine for use

  • Published at 12:31 pm June 15th, 2021
J&J’s vaccine
File photo: Vials with a sticker reading, 'Covid-19 / Coronavirus vaccine / Injection only' and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020 Reuters

The DGDA has approved the vaccine following the scrutiny of documents related to its clinical trial and upon completion of necessary procedures

Amid a growing demand for Covid-19 vaccines, Bangladesh's drug authorities have approved the emergency use of the single-dose Covid-19 vaccine produced by Janssen Pharmaceuticals, owned by US-based multinational corporation Johnson & Johnson (J&J).

The Directorate General of Drug Administration (DGDA) approved the Emergency Use Authorization (EUA) for the Janssen vaccine on Tuesday afternoon, according to a press release issued by DGDA chief Maj Gen Mahbubur Rahman.

The development comes a day after Health Minister Zahid Maleque announced that the nationwide Covid-19 vaccination campaign, which stalled due to a suspension of supply back in April, would resume on June 19.

The approval for the Janssen vaccine came after the DGDA scrutinized the documents related to the vaccine's clinical trial, CMC part, regulatory status and also after receiving recommendations from a public health emergency panel which examined the efficacy of the vaccine.

Also Read - Health Minister: Covid-19 vaccination to resume from June 19

Other than this, five more vaccines -- all double-dose ones -- have so far been cleared by the DGDA for use in Bangladesh.

They are: the Oxford-AstraZeneca vaccine, Russia’s Sputnik V, China’s Sinopharm and Sinovac, and the Pfizer-BioNTech vaccine.

As yet, the government has administered the Oxford-AstraZeneca and Sinopharm vaccines in the country.

According to the press release, the Maternal Neonatal Child and Adolescent Health (MNCAH) unit under the DGDA will act as the local agency of the company.

The single-dose vaccine will be preserved at 2-8 degrees Celsius.

People aged 18 or above will get the vaccine once the process of administering the vaccine gets underway.

Produced by Janssen-Cilag International NV of Belgium, the vaccine was enlisted by the European Medicine Authority for emergency use on February 11 and later by the US FDA on February 27, and the World Health Organization (WHO) on March 12.

Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail